UroGen Pharma Ltd. (URGN) Return on Equity (ROE) and Return on Assets (ROA)
UroGen Pharma Ltd. (URGN) return on equity (ROE) and return on assets (ROA) history. Calculate ROE/ROA in Excel with MarketXLS.
ROE & ROA Data
| Period | ROE | ROA |
|---|---|---|
| 2017-12-31 | -29.19% | -26.47% |
| 2018-12-31 | -83.98% | -73.06% |
| 2019-12-31 | -58.32% | -51.95% |
| 2020-12-31 | -133.34% | -105.31% |
| 2021-12-31 | -1317.25% | -92.55% |
| 2022-12-31 | N/A | -80.95% |
| 2023-12-31 | N/A | -57.34% |
| 2024-12-31 | N/A | -44.41% |
| 2025-12-31 | N/A | -76.57% |
Return on equity divides net income by total shareholder equity at the period end. Return on assets divides the same net income by total assets at the period end. A figure reads N/A when the divisor is missing or not positive, because the ratio is not meaningful then.
Get UroGen Pharma Ltd. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Return_on_Average_Equity("URGN", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | URGN | $46.86 | +0.13% | 0.76M |
| 3 | ||||
| 4 | ||||
| 5 |